Artivion Inc
NYSE:AORT

Watchlist Manager
Artivion Inc Logo
Artivion Inc
NYSE:AORT
Watchlist
Price: 28.27 USD 0.86% Market Closed
Market Cap: 1.2B USD
Have any thoughts about
Artivion Inc?
Write Note

Artivion Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Artivion Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Artivion Inc
NYSE:AORT
Revenue
$354m
CAGR 3-Years
12%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Revenue
$20.2B
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Revenue
$15.9B
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
8%
Stryker Corp
NYSE:SYK
Revenue
$22B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Revenue
$41.2B
CAGR 3-Years
-1%
CAGR 5-Years
6%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$7.9B
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
14%
No Stocks Found

Artivion Inc
Revenue Breakdown

Breakdown by Geography
Artivion Inc

Total Revenue: 354m USD
100%
Domestic: 179.5m USD
50.7%
Foreign: 174.5m USD
49.3%

Breakdown by Segments
Artivion Inc

Total Revenue: 354m USD
100%
Products: 261.2m USD
73.8%
North America: 187.6m USD
53%
EMEA: 114.8m USD
32.4%
Preservation Services: 92.8m USD
26.2%
Apac: 33.6m USD
9.5%
Latam: 18m USD
5.1%
Show More
Show Less

Artivion Inc
Glance View

Market Cap
1.2B USD
Industry
Health Care

Artivion, Inc. focuses on developing solutions that address cardiac and vascular surgeons' clinical challenges in treating patients with aortic diseases. The company is headquartered in Kennesaw, Georgia and currently employs 1,300 full-time employees. The firm is focused on developing various solutions that address cardiac and vascular surgeons' challenges in treating patients with aortic diseases. The firm's four groups of products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts, and surgical sealants. Artivion's cryopreserved cardiac and vascular allograft tissues help in restoring surgeries for adults and pediatric patients. The company offers surgical sealant through BioGlue product. Its surgical aortic valve replacement solutions include On-X Aortic Heart Valves and CryoValve SG Pulmonary Valve Allograft for the Ross procedure. The firm's mitral valve solutions include Chord-X for mitral valve repair and On-X Mitral Heart Valve. Artivion's Cardiac and Vascular Ancillary solutions provide complementary support for the patient's cardiac and vascular surgical procedures.

AORT Intrinsic Value
24.23 USD
Overvaluation 14%
Intrinsic Value
Price

See Also

What is Artivion Inc's Revenue?
Revenue
354m USD

Based on the financial report for Dec 31, 2023, Artivion Inc's Revenue amounts to 354m USD.

What is Artivion Inc's Revenue growth rate?
Revenue CAGR 5Y
6%

Over the last year, the Revenue growth was 13%. The average annual Revenue growth rates for Artivion Inc have been 12% over the past three years , 6% over the past five years .

Back to Top